Prot# CAT-8015-1001: A Phase 1, Multicenter, Dose Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Hairy Cell Leukemia (HCL)

  • Tallman, Martin Stuart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/19/07 → 6/19/10

Funding

  • INC Research, LLC (CAT-8015-1001 // CAT-8015-1001)
  • Cambridge Antibody Technology (CAT-8015-1001 // CAT-8015-1001)